Navigation Links
New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis
Date:9/3/2008

The American College of Rheumatology Research and Education Foundation's

Within Our Reach Campaign Yields Significant Advances in Detecting,

Treating and Understanding RA

ATLANTA, Sept. 3 /PRNewswire/ -- For the first time during its unprecedented initiative to find a cure for rheumatoid arthritis, the American College of Rheumatology Research and Education Foundation is releasing new information acquired from research funded by the Within Our Reach: Finding a Cure for Rheumatoid Arthritis campaign.

Doctors and scientists from across the nation are utilizing more than $12 million in grants awarded by the ACR REF to investigate critical issues including early detection of RA, novel treatment pathways as well as improved patient-provider interaction and patient care. While research is still underway, the REF is encouraged by the progress made thus far and is pleased to announce the new and promising knowledge which RA researchers will continue to build upon as studies continue.

"The REF is committed to funding RA research that is not being done elsewhere, and supporting scientists and doctors who are most prepared and motivated to work on finding a cure," said Dr. Leslie J. Crofford, president of the REF. "The quality and value of the studies in progress is evidence that the Within Our Reach campaign to is critical and must continue."

Viewed as one of the most disabling types of arthritis, RA affects nearly 1.3 million Americans. But, because of rapidly advancing research into the fundamentals of inflammation, the outlook for those suffering from RA has improved dramatically over the past 25 years. Recent advances in treatment have made it possible to stop, or at least slow the progression of joint damage. Additionally, new therapies that target inflammation are being developed.

Today the Within our Reach campaign is supporting 30 innovative research studies and highlights of new information gained
'/>"/>

SOURCE ACR Research and Education Foundation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
2. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
3. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
4. Researchers at Cleveland Clinic Identify Site of Dysfunction in HDL, Carrier of Good Cholesterol
5. Video: New Research Discovers Independent Brain Networks Control Human Walking
6. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
7. Cleveland Clinic Researchers Identify Mechanism Behind Platelet Function and Potentially Fatal Blood Clot Formation
8. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
9. Diabetes Research Institute Invention Promotes Growth of Stem Cells into Insulin-Producing Cells
10. Researchers Identify Virus Possibly Responsible for Declining Honeybee Population Using 454 Sequencing Technology from Roche
11. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...H,Fla.,Nov.25/PRNewswire-FirstCall/--Formanyofthem...illionlivingwithuntreated hearingloss ,theholidays..., Dr.Beyer,seniorvicepresidentofHearUSA(Amex: EA...s companies,saidstudieshavelinkedhearinglosstostre...eintensifiedatholidaygatheringswithfamiliesandfrie...
(Date:11/25/2009)...,Nov.25/PRNewswire-Asia-FirstCall/--ChinaSkyOne,Me...daq: CSKI ),a,leadingfullyintegratedpharmaceutical...sinthePeople,sRepublicofChina("PRC"),today,announc...stitutefor,theControlofPharmaceuticalandBiological...s:itsDiagnosticKitforHumanProstateSpecific,Antigen...
(Date:11/25/2009)...K,N.J.,Nov.25/PRNewswire/--SwissrayInternational,I... ddR )systems,announcedtodaythatitsoperationshaveb...wtowardsgrowingSwissray,smedicalimagingbrand.Theac...aswellascontractsandinventory.After25yearsofsucces...ftechnologicaladvancementswithstableandsteadygrowt...
Breaking Medicine Technology:For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3Swissray International Announces New Ownership 2Physical Therapists Say Proper Fit and Use of Walkers and Canes Can Prevent Fall Related Injuries in Elderly 51326 1Physical Therapists Say Proper Fit and Use of Walkers and Canes Can Prevent Fall Related Injuries in Elderly 51326 2New lab test offers better prediction of HIV microbicide safety 9203 1New lab test offers better prediction of HIV microbicide safety 9203 2New lab test offers better prediction of HIV microbicide safety 9203 3Senesco Technologies Enters Into Agreement For Up To 241 0 Million In Financing 12970 1Senesco Technologies Enters Into Agreement For Up To 241 0 Million In Financing 12970 2Senesco Technologies Enters Into Agreement For Up To 241 0 Million In Financing 12970 3Senesco Technologies Enters Into Agreement For Up To 241 0 Million In Financing 12970 4
...al announced today,that it has begun enrollment of...an (FIM) drug eluting coronary stent clinical tria...valuating Atrium,s CINATRA(TM),voclosporin coated ...s a prospective, multi-center, single blind,random...sporin coated,coronary stent system, which will be...
... Significant and Clinically Relevant, Results fo...Neuropathy, SAN FRANCISCO, June 8 Sangamo BioSci...esentation of encouraging Phase,1b clinical data f...ientific Sessions of the American Diabetes Associa...ntitled, "Evidence of Neuroregeneration,Using Vasc...
Other Medicine Technology:Atrium Medical Corporation Announces First Implant of First-in-Man CINATRA(TM) Voclosporin Coated Coronary Stent 2Sangamo BioSciences Announces Presentation of Phase 1b ZFP Therapeutic Data at American Diabetes Association Meeting 2Sangamo BioSciences Announces Presentation of Phase 1b ZFP Therapeutic Data at American Diabetes Association Meeting 3Sangamo BioSciences Announces Presentation of Phase 1b ZFP Therapeutic Data at American Diabetes Association Meeting 4Sangamo BioSciences Announces Presentation of Phase 1b ZFP Therapeutic Data at American Diabetes Association Meeting 5Sangamo BioSciences Announces Presentation of Phase 1b ZFP Therapeutic Data at American Diabetes Association Meeting 6Sangamo BioSciences Announces Presentation of Phase 1b ZFP Therapeutic Data at American Diabetes Association Meeting 7Sangamo BioSciences Announces Presentation of Phase 1b ZFP Therapeutic Data at American Diabetes Association Meeting 8Sangamo BioSciences Announces Presentation of Phase 1b ZFP Therapeutic Data at American Diabetes Association Meeting 9
(Date:11/25/2009)..., TORONTO,Nov.25/PRNewswire/-SentinelleMedica...cedvisualizationsoftwarelaunchesasuiteofnewleading...ngsoftwareplatformatthisyear,sRadiologicalSocietyo...ec.5,2009(Booth5800,HallA).Theapplicationsleverage...pecializedMRIimagingcoilsandsupportmultipleimaging...
(Date:11/25/2009)..., SANFRANCISCO,Nov.25/PRNewswire/--TheBayArea...rst Winter Spare the Air Alert forTh...turedfirelogsoranyothersolidfuel,bothindoorsandout...ealthyairqualitytomorrow,"saidJackBroadbent,execut...dentstorespectthehealthoftheirneighborsandfellowco...
(Date:11/25/2009)..., A fortuitous discovery that grew out of a colla...ld potentially offer hope to the nearly 10 million...ease. , Also known as hardening of the arter...mon circulatory problem in which narrowed arteries...considered a red flag for vascular disease, heart ...
(Date:11/25/2009)... Evaluation and treatment ... Woodstock (Vocus) November 25, 2009 -- ... nasal vaccines and H1N1 vaccine shots at four Cen... another shipment of vaccine has arrived. The clin...l Lake and McHenry and will be open as follows: , ...
(Date:11/25/2009)..., NEWYORK,Nov.25/PRNewswire/-- MISSIONSkincar...n$1millionforSt.Jude.AspartofGNC,sannualSt.Jude Th...ry MISSIONSkincare,s new SUPER-C(TM)LipBalm will...eopportunitytomakea$1,$5or$10donationatcheckoutato...toraisemorethan$1millionforSt.Judeduringtheir2009 ...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2
...an. 14 A special series of papers in the peer-r...ensive look at future directions of research on pi...dvance the scientific understanding of the genetic...e available online at www.liebertpub.com/zeb , ...
...y 14, 2009 - A new study suggests that adult bone ...of artificial skin. The findings mark an advanceme...ethod of organ reconstruction. The study is publis...l Organs (INFA) and the International Society for ...
... 14 A surge of arctic air forecast to arrive in P...chills that could lead to serious health problems,...tures across Pennsylvania are expected to range fr...uce the risk of hypothermia, which is a very real ...
...ation rapid access journal report: , , Study high...e ambulance,s arrival on the scene was similar bet... began after ambulances arrived and continued unti...art conditions may not be recognized as readily, t...
... April 11, 2011, with $8.05 Conversion Price , ...IC ), the innovator and leader of BioZ(R) impedanc...hat the Company,s note holders had not exercised t...e holders had an opportunity to elect, in January ...
...genetics and who would benefit from treatments , ...w research may one day help physicians identify th... most likely to benefit from certain treatments. ,...ony of receiving treatments that aren,t going to h...
Other Medicine News:Health News:Zebrafish Journal Publishes Skin Pigmentation Studies That Shed Light on the Evolution of Race 2Health News:Zebrafish Journal Publishes Skin Pigmentation Studies That Shed Light on the Evolution of Race 3Health News:Study uses bone marrow stem cells to regenerate skin 2Health News:Department of Health Urges Pennsylvanians to Prepare For Dangerously Cold Weather 2Health News:Women May Be More Likely to Experience EMS Delays for Heart Care 2Health News:Women May Be More Likely to Experience EMS Delays for Heart Care 3Health News:CardioDynamics Announces Investors Retain $5.25 Million 8% Convertible Debt Securities 2Health News:Researchers Zero In on GI Cancers 2Health News:Researchers Zero In on GI Cancers 3Health News:Researchers Zero In on GI Cancers 4
VS II Standalone
...workflow and reduce costs associated with sample-p...tomation system. Designed for the medium- to high-...y automates labor-intensive specimen processing ta...g sample identification, centrifugation, decapping...
... Clinical is an open platform for clinical diagnos... in deck sizes of 75, 100, 150 and 200 cm that al...atory space and throughput requirements. Tecan wil...res to allow new applications and to evolve the qu...
AccelNet Laboratory Automation Network
Medicine Products: